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Clinics and pathology 
Disease 
Chronic eosinophilic leukemia 
Epidemiology 
One case to date, a 71-year-old female patient with 
chronic eosinophilic leukemia in accelerated phase 
(Walz et al., 2006). 
Prognosis 
Remission was obtained with imatinib, but the patient 
relapsed with imatinib-resistant acute myeloid 
leukemia that was characterized by a normal karyotype, 
absence of detectable CDK5RAP2-PDGFRA mRNA, 
and a newly acquired G12D NRAS mutation. 





Receptor tyrosine kinase. Gain-of-function mutations 
of PDGFRA are implicated in a subset of 
gastrointestinal stromal tumors (Heinrich et al., 2003). 
PDGFRA has also been involved in translocations, 
making hybrid genes with STRN (2p22), FIP1L1 






Centrosomal protein; regulates CDK5; binds EB1. The 
CDK5RAP2-EB1 complex stimulates microtubule 
assembly (Fong et al., 2009); critical for centrosomal 
localization of dynein throughout the cell cycle (Lee 
and Rhee, 2010). CDK5RAP2-knockdown cells have 
increased resistance to paclitaxel and doxorubicin 
(Zhang et al., 2009). Homozygous mutations in 
CDK5RAP2 can cause microcephaly (Bond et al., 
2005). 




In-frame fusion between exon 13 of the CDK5RAP2, a 
40 bp insert from an inverted sequence of PDGFRA 
intron 9, and a truncated PDGFRA exon 12. No 
reciprocal PDGFRA-CDK5RAP2 transcript. 
Fusion protein 
Description 
N-term CDK5RAP2 - C-term PDGFRA; 1003 amino 
acids; contains 494 amino acids, including several 
potential dimerization domains, of CDK5RAP2 and 
509 amino acids from PDGFRA tyrosine kinase 
domains. 
Oncogenesis 
Constitutive tyrosine kinase activity is likely. 
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